vs
bioAffinity Technologies, Inc.（BIAF）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
bioAffinity Technologies, Inc.的季度营收约是Arcadia Biosciences, Inc.的1.8倍（$1.6M vs $901.0K），Arcadia Biosciences, Inc.净利率更高（-148.3% vs -197.0%，领先48.7%），Arcadia Biosciences, Inc.同比增速更快（-25.8% vs -27.8%），过去两年Arcadia Biosciences, Inc.的营收复合增速更高（-4.5% vs -18.6%）
bioAffinity Technologies是一家处于临床阶段的生物技术企业，专注于研发可用于癌症、呼吸系统疾病早期检测的非侵入性体外诊断产品，面向全球医疗市场，致力于提供高准确率的便捷诊断方案，改善患者诊疗体验与预后效果。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
BIAF vs RKDA — 直观对比
营收规模更大
BIAF
是对方的1.8倍
$901.0K
营收增速更快
RKDA
高出2.0%
-27.8%
净利率更高
RKDA
高出48.7%
-197.0%
两年增速更快
RKDA
近两年复合增速
-18.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6M | $901.0K |
| 净利润 | $-3.1M | $-1.3M |
| 毛利率 | — | 21.4% |
| 营业利润率 | -196.9% | -152.8% |
| 净利率 | -197.0% | -148.3% |
| 营收同比 | -27.8% | -25.8% |
| 净利润同比 | -5.7% | 67.1% |
| 每股收益（稀释后） | $-3.59 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIAFRKDA
| Q4 25 | $1.6M | $901.0K | ||
| Q3 25 | $1.4M | $1.3M | ||
| Q2 25 | $1.3M | $1.5M | ||
| Q1 25 | $1.9M | $1.2M | ||
| Q4 24 | $2.2M | $1.2M | ||
| Q3 24 | $2.4M | $1.5M | ||
| Q2 24 | $2.4M | $1.3M | ||
| Q1 24 | $2.4M | $987.0K |
净利润BIAFRKDA
| Q4 25 | $-3.1M | $-1.3M | ||
| Q3 25 | $-5.1M | $856.0K | ||
| Q2 25 | $-4.1M | $-4.5M | ||
| Q1 25 | $-2.7M | $2.6M | ||
| Q4 24 | $-3.0M | $-4.1M | ||
| Q3 24 | $-2.0M | $-1.6M | ||
| Q2 24 | $-2.1M | $1.1M | ||
| Q1 24 | $-2.0M | $-2.4M |
毛利率BIAFRKDA
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 31.9% | ||
| Q3 24 | — | 32.9% | ||
| Q2 24 | — | 51.5% | ||
| Q1 24 | — | 52.3% |
营业利润率BIAFRKDA
| Q4 25 | -196.9% | -152.8% | ||
| Q3 25 | -158.6% | -88.5% | ||
| Q2 25 | -198.2% | -34.4% | ||
| Q1 25 | -141.7% | 44.2% | ||
| Q4 24 | -133.5% | -187.7% | ||
| Q3 24 | -84.0% | -114.5% | ||
| Q2 24 | -87.1% | — | ||
| Q1 24 | -80.8% | -160.9% |
净利率BIAFRKDA
| Q4 25 | -197.0% | -148.3% | ||
| Q3 25 | -349.3% | 65.7% | ||
| Q2 25 | -319.9% | -306.4% | ||
| Q1 25 | -143.5% | 216.6% | ||
| Q4 24 | -134.4% | -334.5% | ||
| Q3 24 | -85.1% | -104.9% | ||
| Q2 24 | -88.0% | 81.2% | ||
| Q1 24 | -81.5% | -245.5% |
每股收益（稀释后）BIAFRKDA
| Q4 25 | $-3.59 | $-0.97 | ||
| Q3 25 | $-4.74 | $0.62 | ||
| Q2 25 | $-0.17 | $-3.26 | ||
| Q1 25 | $-0.16 | $1.90 | ||
| Q4 24 | $-17.27 | $-2.99 | ||
| Q3 24 | $-4.84 | $-1.18 | ||
| Q2 24 | $-0.19 | $0.78 | ||
| Q1 24 | $-0.20 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.3M | $4.1M |
| 总资产 | $11.0M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BIAFRKDA
| Q4 25 | $6.4M | $4.6M | ||
| Q3 25 | $7.7M | $5.9M | ||
| Q2 25 | $802.8K | $4.4M | ||
| Q1 25 | $444.7K | $3.2M | ||
| Q4 24 | $1.1M | $4.2M | ||
| Q3 24 | $756.6K | $6.6M | ||
| Q2 24 | $801.3K | $8.1M | ||
| Q1 24 | $2.5M | $8.5M |
股东权益BIAFRKDA
| Q4 25 | $7.3M | $4.1M | ||
| Q3 25 | $8.9M | $5.4M | ||
| Q2 25 | $-2.1M | $4.5M | ||
| Q1 25 | $1.4M | $8.9M | ||
| Q4 24 | $2.6M | $6.2M | ||
| Q3 24 | $3.1M | $10.3M | ||
| Q2 24 | $3.4M | $11.7M | ||
| Q1 24 | $5.3M | $10.6M |
总资产BIAFRKDA
| Q4 25 | $11.0M | $6.5M | ||
| Q3 25 | $11.5M | $8.6M | ||
| Q2 25 | $4.8M | $7.8M | ||
| Q1 25 | $5.5M | $13.0M | ||
| Q4 24 | $6.5M | $13.5M | ||
| Q3 24 | $6.6M | $15.2M | ||
| Q2 24 | $6.7M | $17.4M | ||
| Q1 24 | $8.0M | $16.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.6M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $-2.6M | — |
| 自由现金流率自由现金流/营收 | -160.7% | — |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.4M | — |
8季度趋势，按日历期对齐
经营现金流BIAFRKDA
| Q4 25 | $-2.6M | $-861.0K | ||
| Q3 25 | $-2.5M | $-257.0K | ||
| Q2 25 | $-2.6M | $-2.0M | ||
| Q1 25 | $-1.6M | $-1.6M | ||
| Q4 24 | $-1.7M | $-2.2M | ||
| Q3 24 | $-1.7M | $-1.8M | ||
| Q2 24 | $-1.5M | $-2.5M | ||
| Q1 24 | $-2.3M | $-3.2M |
自由现金流BIAFRKDA
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-2.5M | — | ||
| Q2 25 | $-2.7M | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | $-1.6M | $-2.5M | ||
| Q1 24 | $-2.4M | $-3.2M |
自由现金流率BIAFRKDA
| Q4 25 | -160.7% | — | ||
| Q3 25 | -171.8% | — | ||
| Q2 25 | -209.6% | — | ||
| Q1 25 | -91.3% | — | ||
| Q4 24 | -76.0% | — | ||
| Q3 24 | -73.1% | — | ||
| Q2 24 | -65.1% | -188.3% | ||
| Q1 24 | -99.2% | -326.5% |
资本支出强度BIAFRKDA
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 2.7% | 0.0% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.4% | 0.0% | ||
| Q2 24 | 1.2% | 0.2% | ||
| Q1 24 | 1.7% | 1.3% |
现金转化率BIAFRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
